EUVIMEDEUVIMED entdecken
Crossref

Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway

Na Young Kim iD, Yejin Hong, Seung Ho Baek, Dongwoo Nam, Ducdat Le, Mina Lee, Jae-Young Um, Kwang Seok Ahn iD

Journal of Pharmacy and Pharmacology · 03.07.2026 · 78 (7)

DOI: 10.1093/jpp/rgag071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 04.07.2026. Verfasst von Na Young Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Epithelial-Mesenchymal Transition, Colorectal Neoplasms, Receptors, CXCR4. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Norisoboldine (NOR), an isoquinoline alkaloid from Radix Linderae, has known anti-inflammatory properties, but its role in colorectal cancer remains unclear.

Methods

HCT-15, SW480, and HT-29 cells were treated with NOR and assessed via MTT, Western blotting, zymography, wound-healing, invasion assays, and STAT3 loss/gain-of-function experiments. Molecular docking explored NOR–STAT3 interaction. Key findings NOR showed limited cytotoxicity at the concentrations used for mechanistic experiments. NOR decreased the expression of mesenchymal and metastasis-associated proteins, including Vimentin, Twist, Snail, CXCR4, CXCR7, MMP-2, and MMP-9, while increasing E-cadherin and Occludin levels. NOR also reduced gelatinolytic activity and attenuated CXCL12-enhanced migration and invasion. In parallel, NOR decreased phosphorylation of STAT3 and its upstream kinases JAK1, JAK2, and Src, and reduced nuclear accumulation of STAT3. STAT3 knockdown lowered CXCR4, CXCR7, and Snail expression, whereas STAT3 overexpression produced the opposite pattern; NOR partly reversed these changes. Docking analysis suggested that NOR may interact with the SH2 domain of STAT3, although this requires biochemical validation.

Conclusion

NOR attenuates epithelial–mesenchymal transition and invasive phenotypes in colorectal cancer cells via JAK/STAT3 suppression, positioning it as a candidate anti-metastatic modulator. Further in vivo and target-engagement studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorEpithelial-Mesenchymal TransitionColorectal NeoplasmsReceptors, CXCR4AlkaloidsHumansSignal TransductionMolecular Docking SimulationCell Line, TumorCell MovementJanus KinasesHT29 Cells

Stichwörter der Autor:innen

JAKSTAT3epithelial–mesenchymal transitionmetastasisnorisoboldine

Substanzen

STAT3 Transcription FactorReceptors, CXCR4AlkaloidsSTAT3 protein, humannorisoboldineCXCR4 protein, humanJanus Kinases

Autor:innen und Institutionen

  • Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
  • Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital, Seoul 02447, Republic of Korea.
  • College of Korean Medicine, Dongguk University, 32 Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 10326, Republic of Korea.
  • Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungangno, Suncheon, Jeonnam 57922, Republic of Korea.
  • Department of Natural Cosmetics Science and AI Digital Bioscience Research Institute, Graduate School, Sunchon National University, 255 Jungangno, Suncheon, Jeonnam 57922, Republic of Korea.

ORCID-Profile: Na Young Kim, Kwang Seok Ahn

Zitieren

APA

Kim, N. Y., Hong, Y., Baek, S. H., Nam, D., Le, D., Lee, M., Um, J. Y., & Ahn, K. S. (2026). Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway. Journal of Pharmacy and Pharmacology, 78(7). https://doi.org/10.1093/jpp/rgag071

Vancouver

Kim NY, Hong Y, Baek SH, Nam D, Le D, Lee M, et al. Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway. Journal of Pharmacy and Pharmacology. 2026;78(7). doi:10.1093/jpp/rgag071

BibTeX
@article{Kim2026,
  author = {Kim, Na Young and Hong, Yejin and Baek, Seung Ho and Nam, Dongwoo and Le, Ducdat and Lee, Mina and Um, Jae-Young and Ahn, Kwang Seok},
  title = {Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  volume = {78},
  number = {7},
  doi = {10.1093/jpp/rgag071}
}
Kostenlos starten →